Index by author
Markman, Maurie
- You have accessBrain metastases: Presentation, evaluation, and managementMark A. Chidel, MD, John H. Suh, MD and Gene H. Barnett, MDCleveland Clinic Journal of Medicine February 2000, 67 (2) 120-127;
Prompt diagnosis and treatment can prolong the patient’s life and improve the quality of his or her remaining days.
Mossad, Sherif B.
- You have accessAntiviral agents for treating influenzaJennifer K. Long, PHARMD, Sherif B. Mossad, MD and Morton P. Goldman, PHARMDCleveland Clinic Journal of Medicine February 2000, 67 (2) 92-95;
We now have four antiviral drugs for treating influenza. Who should receive them? Which one to use?
Novy, Margareta
- You have accessAre strict vegetarians at risk of vitamin B12 deficiency?Margareta Novy, MPH, RD, LDCleveland Clinic Journal of Medicine February 2000, 67 (2) 87;
Patients who avoid or limit animal products in their diets should be encouraged to take vitamin B12 supplements or eat fortified foods.
Roe, Matthew T.
- You have accessGlycoprotein Ilb/IIIa inhibitors in acute coronary syndromesMatthew T. Roe, MD, Shelly K. Sapp, MS and A. Michael Lincoff, MDCleveland Clinic Journal of Medicine February 2000, 67 (2) 131-140;
These potent antiplatelet agents constitute a breakthrough, hut questions remain about their safety, cost-effectiveness, and proper empiric use. With an illustration explaining the paradoxical prothrombotic effect of fibrinolytic drugs.
Saadeh, Sherif
- You have accessThe spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitisSherif Saadeh, MD and Zobair M. Younossi, MD, MPHCleveland Clinic Journal of Medicine February 2000, 67 (2) 96-104;
This recently discovered disease is a common cause of elevated liver enzymes. We are beginning to understand which patients are at greatest risk of progressive liver disease.
Sapp, Shelly K.
- You have accessGlycoprotein Ilb/IIIa inhibitors in acute coronary syndromesMatthew T. Roe, MD, Shelly K. Sapp, MS and A. Michael Lincoff, MDCleveland Clinic Journal of Medicine February 2000, 67 (2) 131-140;
These potent antiplatelet agents constitute a breakthrough, hut questions remain about their safety, cost-effectiveness, and proper empiric use. With an illustration explaining the paradoxical prothrombotic effect of fibrinolytic drugs.
Suh, John H.
- You have accessBrain metastases: Presentation, evaluation, and managementMark A. Chidel, MD, John H. Suh, MD and Gene H. Barnett, MDCleveland Clinic Journal of Medicine February 2000, 67 (2) 120-127;
Prompt diagnosis and treatment can prolong the patient’s life and improve the quality of his or her remaining days.
Vidt, Donald G.
- You have accessIs there an advantage to combination therapy with ACE inhibitors and angiotensin II-receptor blockers?Donald G. Vidt, MDCleveland Clinic Journal of Medicine February 2000, 67 (2) 89-91;
Theoretic reasons and small studies suggest the two types of drugs may be useful in combination, but a definitive answer awaits the results of larger studies.
Wilke, William S.
- You have accessIs God good for your health? The role of spirituality in medical careDavid B. Larson, MD, MSPH and Harold G. Koenig, MDCleveland Clinic Journal of Medicine February 2000, 67 (2) 80-84;
Many studies found that religious belief and practice have a positive effect on physical and mental health. Physicians should try to understand and respect their patients’ beliefs.
- You have accessAntiviral agents for treating influenzaJennifer K. Long, PHARMD, Sherif B. Mossad, MD and Morton P. Goldman, PHARMDCleveland Clinic Journal of Medicine February 2000, 67 (2) 92-95;
We now have four antiviral drugs for treating influenza. Who should receive them? Which one to use?
Younossi, Zobair M.
- You have accessThe spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitisSherif Saadeh, MD and Zobair M. Younossi, MD, MPHCleveland Clinic Journal of Medicine February 2000, 67 (2) 96-104;
This recently discovered disease is a common cause of elevated liver enzymes. We are beginning to understand which patients are at greatest risk of progressive liver disease.